EDI-OCT and CVI findings can shed light on choroidal vascular physiology following COVID-19 pneumonia
Investigators measured the choroidal structures using enhanced depth imaging optical coherence tomography
Winterthur, Switzerland welcomes second annual Winterthur Ophthalmology Symposium
After a successful inaugural WOS in 2024, the congress will feature new lectures and wetlabs in its sophomore year
Study assesses efficacy of cyclosporine A 0.1% cationic emulsion drops for postoperative discomfort
Prophylactic cyclosporine A 0.1% eye drops were associated with improved ocular surface homeostasis and reduced inflammation
First patient dosed in Phase 1/2 ASTRA study for Stargardt disease therapy SB-007 (SpliceBio)
SpliceBio continues to actively enroll patients in the ASTRA study and accompanying POLARIS trial
Study links new gender and genetic factors to Fuchs Endothelial Corneal Dystrophy
A large-scale study indicates women are more likely to develop the inherited corneal condition
Her Royal Highness The Duchess of Edinburgh delivers keynote address on gender equity in eye care
The UN Friends of Vision group meeting coincided with International Women's Day and the UN Commission on the Status of Women
Advanced therapies in neovascular AMD and DMO: Experts weigh in
A clinician panel illuminates current treatment paradigms and best practices for reducing treatment burden
OKYO Pharma files US FDA Fast Track application for neuropathic corneal pain treatment urcosimod
Urcosimod, formerly known as OK-101, showed clear statistical significance in multiple endpoints in a recently completed Phase 2 trial
Renal dysfunction negatively impacts effect of diabetic macular oedema therapy
Additionally, the prognosis of macular oedema may help clinicians evaluate renal function, investigators reported
Experts say revakinagene taroretcel-lwey approval may represent dawn of new treatments for neurodegenerative conditions
Clinicians react to the US approval of revakinagene taroretcel-lwey (Encelto; Neurotech Pharmaceuticals) for macular telangiectasia type 2
Nicox SA shares research findings from NCX 470 Mont Blanc Phase 3 glaucoma trial
The novel nitric oxide-donating bimatoprost eye drop is designed to lower IOP in patients with open-angle glaucoma or ocular hypertension
NASA astronaut and clinical lead will deliver keynote at International SPECTRALIS Symposium
In a keynote speech, Warren Hoburg and Tyson J. Brunstetter, OD, PhD, will discuss in-orbit imaging and spaceflight-associated neuro-ocular syndrome
The Fred Hollows Foundation issues a call to action for International Women's Day
The Australia-based organisation is partnering with the UN Friends of Vision group for an event on 11 March
US FDA approves revakinagene taroretcel-lwey (ENCELTO) for macular telangiectasia type 2
The encapsulated cell therapy from Neurotech Pharmaceuticals is the first FDA-approved treatment for MacTel
Comparing postoperative astigmatism following toric IOL implantation VS femtosecond laser-assisted astigmatic keratotomy
The toric IOLs demonstrated a slight advantage over FSAK and were associated with better postoperative uncorrected distance visual acuity
EMA provides positive ATMP opinion for gene therapy products OCU410 and OCU410ST
The modifier gene therapies from Ocugen target geographic atrophy and Stargardt disease
Novel stem cell therapy restores corneal damage previously believed irreversible
The authors said their results provide strong support that cultivated autologous limbal epithelial cell transplantation is safe and feasible
Cognition Therapeutics announces publication reviewing potential of zervimesine (CT1812) in dry AMD
One in vitro study included in the manuscript was conducted in collaboration with researchers at the University of Southhampton in the United Kingdom
Study: Cigarette smoking negatively affects choroidal vascularity
The investigators' findings suggest that CVI is a valuable noninvasive predictive biomarker for monitoring vascular changes in patients who smoke
Association between the triglyceride-glucose index and central retinal artery occlusion
The researchers reported a “notable” correlation which could serve as a predictive biomarker
Australian Society of Ophthalmologists appoints three new board members
In the group of new appointees, the organisation welcomed community members who are passionate about advocacy and education
Preview: The ESCRS Winter Meeting comes to Athens
This year, the European Society of Cataract and Refractive Surgeons has partnered with the Hellenic Society of Intraocular Implant and Refractive Surgery
Report compares rates of sexual harassment and gendered discrimination in ophthalmology
More respondents reported experiencing sexual harassment than in a survey conducted 5 years earlier
Zeiss Visumax 800 with SMILE pro software receives NMPA approval in China
The Visumax 800 boasts a faster laser pulse repetition rate for shorter procedures
Prevent Blindness highlights free resources during Retinopathy of Prematurity Awareness Week
The initiative marks the second annual ROP Awareness week, running from 24 February to 2 March, 2025
Study demonstrates visual acuity improvements following gene therapy for AIPL1-associated inherited retinal dystrophies
Researchers indicated that paediatric patients with Leber congenital amaurosis experienced improvements in vision
UK MHRA issues approval for Formycon aflibercept biosimilar FYB203 (Ahzantive)
The biosimilar to aflibercept (Eylea) has already received approval in the EU and US
Why education must extend beyond patients to make a difference in diabetic eye disease
Francesco Bandello, MD, FEBO, discusses the Diabetic Eye Conditions Coalition and a five-point call to action
New research illuminates patient dissatisfaction despite successful restoration of vision following cataract surgery
Italian investigators reported that ocular surface conditions such as dry eye disease are key factors in perioperative outcomes, even when patients achieve 20/20 vision
Alcon launches Voyager direct selective laser trabeculoplasty device in the US
Voyager DSLT is already available in select markets in the EU and the UK, and reduces the specialised training required with manual selective laser trabeculoplasty
